Latest news with #financialleadership
Yahoo
08-08-2025
- Business
- Yahoo
Fusemachines Appoints Christine Chambers, Experienced Public Company CFO, as Chief Financial Officer
New Role to Strengthen Financial Leadership and Drive Scalable Growth Through Operational Alignment NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fusemachines, Inc. ('Fusemachines' or the 'Company'), a leading provider of enterprise AI products and services, today announced the appointment of Christine Chambers as the Company's new Chief Financial Officer ('CFO'). In her new role, Christine will play a crucial part in aligning the Company's financial structure with its long-term vision and goal of democratizing AI. Christine is a seasoned CFO with over 20 years of experience in leading financial operations and developing growth strategies across multiple publicly traded companies, including RealNetworks and PetMed Express. With expertise spanning across industries including software technology, education technology, and e-commerce, she brings a passion to drive growth, optimize performance, and enhance shareholder value. 'We're excited to welcome Christine, whose global perspective, deep understanding of AI innovation, and track record of scaling companies during critical growth phases make her a tremendous asset to our team,' said Sameer Maskey, CEO of Fusemachines. 'As we continue to expand our AI products & services, her role will be critical in propelling our business towards newer innovations. Her addition is also an important milestone in strengthening our leadership team to meet the growing need for enterprise-class AI.'As CFO, Christine will focus on building a scalable and efficient financial foundation that supports Fusemachines' next phase of growth. She will play a key role in aligning financial operations with business priorities, enabling data-driven decision-making, and ensuring the company is well-positioned to scale responsibly. Drawing on her deep experience leading finance in high-growth environments—including publicly traded companies—she will help Fusemachines navigate growth with discipline, unlock new opportunities, and accelerate innovation. 'Having led finance at several publicly traded companies, I understand what it takes to support innovation at scale,' said Christine Chambers, CFO of Fusemachines. 'I'm thrilled to bring that experience to Fusemachines at this exciting time, and to help guide its next phase of growth while staying aligned with its vision of broadening access to AI.' About the Proposed Business CombinationOn January 23, 2024, Fusemachines announced that the Company has entered into a definitive business combination agreement (the 'Proposed Business Combination') with CSLM Acquisition Corp. ('CSLM'). Upon closing of the transaction, subject to approvals by CSLM's stockholders and Fusemachines' stockholders and other customary closing conditions, CSLM will be renamed 'Fusemachines, Inc.' and will apply for listing on the Nasdaq Capital Market under the new ticker symbol 'FUSE', to be effective upon consummation of the transaction. About Fusemachines Founded in 2013, Fusemachines is a global provider of enterprise AI products and services, on a mission to democratize AI. Leveraging proprietary AI Studio and AI Engines, the company helps drive the clients' AI Enterprise Transformation, regardless of where they are in their Digital AI journeys. Under the leadership of Chief Executive Officer and founder, Dr. Sameer Maskey, PhD, Adjunct Associate Professor at Columbia University, Fusemachines continues to actively pursue the mission of democratizing AI for the masses by providing high-quality AI education in underserved communities and helping organizations achieve their full potential with AI. Fusemachines is headquartered in New York with operations across Asia, Canada, USA, and Latin learn about Fusemachines, visit Statements This press release contains forward-looking statements. All statements, other than statements of historical fact, included in this press release are forward-looking statements. Forward-looking statements include declarations regarding the Company's beliefs and current expectations. These forward-looking statements are subject to the inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. Some, but not all, of the risks and uncertainties include the following: the consummation of the Proposed Business Combination in a timely manner or at all; the successful listing of the Company's securities on Nasdaq; the Company's ability to comply with Nasdaq's continued listing standards; the Company's regulatory environment (including regulations relating to artificial intelligence); fluctuations in the demand for the Company's products and services; the positive impact the Company's leadership will have on the Company's business and results of operations; general economic conditions; unforeseen or changing circumstances; the Company's ability to retain its existing customers and attract new customers; increased competition; and other risks detailed in the Company's filings made the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date they are made. The Company undertakes no obligation, and does not intend to update these forward-looking statements except as required by Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. It does not constitute a prospectus or prospectus equivalent document. No offering or sale of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable Contact:Gateway GroupRalf EsperFUSE@ 949-574-3860Media Contact:Akshath Bahadur Chhetriakshath@ 212-5075Inicia sesión para acceder a tu portafolio
Associated Press
30-07-2025
- Business
- Associated Press
Austin Lighthouse for the Blind CFO Named One of Austin Business Journal's 2025 Best CFOs
Meg Morreale, CFO of Austin Lighthouse, recognized by Austin Business Journal as one of the region's most innovative and impactful financial leaders. AUSTIN, TX, UNITED STATES, July 30, 2025 / / -- Austin Lighthouse for the Blind is proud to announce that Chief Financial Officer Meg Morreale, CPA, has been named one of Austin Business Journal's 2025 Best CFOs, a distinction honoring the region's most accomplished and innovative financial leaders. The Best CFOs Awards recognize top executives who are shaping Austin's business landscape through exceptional financial strategy, leadership, and impact. This year's honorees represent a range of industries and reflect the economic vitality of Central Texas. Morreale joined Austin Lighthouse for the Blind, a nonprofit dedicated to empowering individuals who are blind or visually impaired, after a distinguished career in healthcare finance. As former Vice President of Finance and Accounting at Baylor Scott & White Health the largest nonprofit health system in Texas she was instrumental in the successful acquisition of FirstCare Health Plans in 2019, leading integration efforts that generated more than $50 million in operational synergies. At Austin Lighthouse, Morreale has transformed the organization's financial operations, introducing data-driven reporting tools, improving forecasting accuracy, and strengthening financial sustainability as the nonprofit continues to expand its workforce development programs. 'Meg brings not only deep financial expertise but a bold vision for what is possible,' said Jim Meehan, CEO of Austin Lighthouse for the Blind. 'Her leadership has elevated our mission and positioned us for long-term impact across the Central Texas community.' With over 25 years of cross-sector experience in engineering, consumer products, healthcare, and startups, Morreale is known for her entrepreneurial approach and commitment to continuous improvement. She holds a Bachelor of Science in Industrial Management from the New Jersey Institute of Technology, an MBA from Fairleigh Dickinson University, and is a licensed CPA in Texas. 'Receiving this recognition is truly an honor,' said Morreale. 'It's a privilege to serve an organization where every dollar we manage directly supports opportunity, dignity, and independence for the blind and visually impaired community.' Morreale resides in Austin with her husband, John, their three children, and their dog, Pandora. About Austin Lighthouse for the Blind Austin Lighthouse for the Blind, is a 501(c)(3) social enterprise, our mission is to empower Texans who are blind or visually impaired by developing skills, building careers, and fostering independence. Learn more at Kelly Schaber, Director of Development Austin Lighthouse for the Blind +1 512-442-2329 email us here Visit us on social media: LinkedIn Instagram Facebook YouTube X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
21-07-2025
- Business
- Yahoo
Sensata Technologies Appoints Andrew Lynch as Executive Vice President and Chief Financial Officer
SWINDON, United Kingdom, July 21, 2025--(BUSINESS WIRE)--Sensata Technologies (NYSE: ST), a global industrial technology company and leading provider of sensors, sensor-rich solutions and electrical protection devices used in mission-critical systems to help its customers address increasingly complex engineering and operating performance requirements, today announced that Andrew Lynch has been named as Sensata's Chief Financial Officer, effective immediately. Mr. Lynch assumes leadership and oversight of Sensata's global financial activities. Stephan Von Schuckmann, CEO stated, "Having originally joined Sensata in 2009, Andrew has a solid track record of successive promotions and significant contributions to the company and is perfectly suited for his new role as our Chief Financial Officer. In addition to his depth of experience, Andrew brings financial acumen, strategic insight, and focus. The Board and I are confident that Andrew will be a key contributor to our efforts to continuously improve financial results and build shareholder value over the long term." Andrew Lynch, CFO said, "I want to thank Stephan and the Board for this opportunity. I am excited to take on this new responsibility and I look forward to continuing to work with our leadership, customers, suppliers, and investors with whom I have built strong relationships over the years. We have significant value creation opportunities available to us, and with the right focus and rigor, I am confident that we can successfully capitalize on those opportunities." About Andrew Lynch Mr. Lynch most recently served as Interim CFO. He previously served as Vice President, Finance for the Performance Sensing Segment since 2023 and has led Sensata's investor relations function since 2024. Previously, he was Vice President, Finance, for the Sensing Solutions Segment from 2021 to 2023. From 2019 to 2023 he served as regional CFO for Europe, where he was responsible for all finance and accounting matters across the region. In 2016 he was promoted to Finance Director for the HVOR business and later assumed additional responsibility for the Aerospace business. In 2011, he was promoted to Corporate Accounting Manager and in 2014 promoted to Integration Controller. He joined Sensata in 2009. Andrew holds a Bachelor of Science degree in Corporate Finance and Accounting from Bentley University. About Sensata Technologies Sensata Technologies is a global industrial technology company striving to create a safer, cleaner, more efficient and electrified world. Through its broad portfolio of mission-critical sensors, electrical protection components and sensor-rich solutions, Sensata helps its customers address increasingly complex engineering and operating performance requirements. With more than 18,000 employees and global operations in 14 countries, Sensata serves customers in the automotive, heavy vehicle & off-road, industrial, and aerospace markets. Learn more at and follow Sensata on LinkedIn, Facebook, X and Instagram. Safe Harbor Statement This news release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by terminology such as "may," "will," "could," "should," "expect," "anticipate," "believe," "estimate," "predict," "project," "forecast," "continue," "intend," "plan," "potential," "opportunity," "guidance," and similar terms or phrases. Forward-looking statements involve, among other things, expectations, projections, and assumptions about future financial and operating results, objectives, business and market outlook, megatrends, priorities, growth, shareholder value, capital expenditures, cash flows, demand for products and services, share repurchases, and Sensata's strategic initiatives, including those relating to acquisitions and dispositions and the impact of such transactions on our strategic and operational plans and financial results. These statements are subject to risks, uncertainties, and other important factors relating to our operations and business environment, and we can give no assurances that these forward-looking statements will prove to be correct. A wide variety of potential risks, uncertainties, and other factors could materially affect our ability to achieve the results either expressed or implied by these forward-looking statements, including, but not limited to, risks related to public health crises, instability and changes in the global markets, supplier interruption or non-performance, the acquisition or disposition of businesses, adverse conditions or competition in the industries upon which we are dependent, intellectual property, product liability, warranty, and recall claims, market acceptance of new product introductions and product innovations, labor disruptions or increased labor costs, and changes in existing environmental or safety laws, regulations, and programs. Investors and others should carefully consider the foregoing factors and other uncertainties, risks, and potential events including, but not limited to, those described in Item 1A: Risk Factors in our most recent Annual Report on Form 10-K and as may be updated from time to time in Item 1A: Risk Factors in our quarterly reports on Form 10-Q or other subsequent filings with the United States Securities and Exchange Commission. All such forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update these statements other than as required by law. View source version on Contacts Media & Investor: James Entwistle+1 (508) 954-1561jentwistle@ investors@
National Post
01-07-2025
- Business
- National Post
Galderma Announces Departure of Its Chief Financial Officer
Article content ZUG, Switzerland — Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization. Article content 'We thank Thomas for his financial leadership and many contributions during his time at Galderma. He played a key role in establishing the financial discipline, operational readiness, and strategic clarity that will continue to guide us forward. We wish him every success in his next role and remain focused on further accelerating Galderma's strong growth – from category leadership to becoming a true powerhouse in dermatology.' FLEMMING ØRNSKOV, M.D., MPH CHIEF EXECUTIVE OFFICER GALDERMA Article content Thomas Dittrich will remain with the company as Chief Financial Officer through Q2 2026 to ensure a seamless transition through the close of the 2025 fiscal year. A successor will be announced in due course. Article content 'I want to thank Flemming, our Board of Directors, our investors, and all my colleagues at Galderma for their support throughout what has been the most impactful transformation and growth journey of my career. I leave holding Galderma in the highest regard, enormously proud of the strides we've made together, and equally excited about Galderma's continued growth momentum and long-term success.' THOMAS DITTRICH CHIEF FINANCIAL OFFICER GALDERMA Article content About Galderma Article content Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: Article content Forward-looking statements Article content Certain statements in this announcement are forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as 'plans', 'targets', 'aims', ' believes', 'expects', 'anticipates', 'intends', 'estimates', 'will', 'may', 'continues', 'should' and similar expressions. These forward-looking statements reflect, at the time, Galderma's beliefs, intentions and current targets/ aims concerning, among other things, Galderma's results of operations, financial condition, industry, liquidity, prospects, growth and strategies and are subject to change. The estimated financial information is based on management's current expectations and is subject to change. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results may differ from those set forth in the forward-looking statements as a result of various factors (including, but not limited to, future global economic conditions, changed market conditions, intense competition in the markets in which Galderma operates, costs of compliance with applicable laws, regulations and standards, diverse political, legal, economic and other conditions affecting Galderma's markets, and other factors beyond the control of Galderma). Neither Galderma nor any of their respective shareholders (as applicable), directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak of the date of this announcement. Statements contained in this announcement regarding past trends or events should not be taken as a representation that such trends or events will continue in the future. Some of the information presented herein is based on statements by third parties, and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, reasonableness, accuracy, completeness or correctness of this information or any other information or opinions contained herein, for any purpose whatsoever. Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof. Article content Article content Article content Article content Article content Contacts Article content For further information: Article content Christian Marcoux, Chief Communications Officer +41 76 315 26 50 Article content Richard Harbinson Corporate Communications Director +41 76 210 60 62 Article content Emil Ivanov Head of Strategy, Investor Relations, and ESG +41 21 642 78 12 Article content Article content Article content
Yahoo
01-07-2025
- Business
- Yahoo
Galderma Announces Departure of Its Chief Financial Officer
Ad hoc announcement pursuant to Art. 53 LR ZUG, Switzerland, July 01, 2025--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization. "We thank Thomas for his financial leadership and many contributions during his time at Galderma. He played a key role in establishing the financial discipline, operational readiness, and strategic clarity that will continue to guide us forward. We wish him every success in his next role and remain focused on further accelerating Galderma's strong growth – from category leadership to becoming a true powerhouse in dermatology." FLEMMING ØRNSKOV, M.D., MPH CHIEF EXECUTIVE OFFICER GALDERMA Thomas Dittrich will remain with the company as Chief Financial Officer through Q2 2026 to ensure a seamless transition through the close of the 2025 fiscal year. A successor will be announced in due course. "I want to thank Flemming, our Board of Directors, our investors, and all my colleagues at Galderma for their support throughout what has been the most impactful transformation and growth journey of my career. I leave holding Galderma in the highest regard, enormously proud of the strides we've made together, and equally excited about Galderma's continued growth momentum and long-term success." THOMAS DITTRICH CHIEF FINANCIAL OFFICER GALDERMA About Galderma Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: Forward-looking statements Certain statements in this announcement are forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", " believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. These forward-looking statements reflect, at the time, Galderma's beliefs, intentions and current targets/ aims concerning, among other things, Galderma's results of operations, financial condition, industry, liquidity, prospects, growth and strategies and are subject to change. The estimated financial information is based on management's current expectations and is subject to change. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial consequences of the plans and events described herein. Actual results may differ from those set forth in the forward-looking statements as a result of various factors (including, but not limited to, future global economic conditions, changed market conditions, intense competition in the markets in which Galderma operates, costs of compliance with applicable laws, regulations and standards, diverse political, legal, economic and other conditions affecting Galderma's markets, and other factors beyond the control of Galderma). Neither Galderma nor any of their respective shareholders (as applicable), directors, officers, employees, advisors, or any other person is under any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak of the date of this announcement. Statements contained in this announcement regarding past trends or events should not be taken as a representation that such trends or events will continue in the future. Some of the information presented herein is based on statements by third parties, and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, reasonableness, accuracy, completeness or correctness of this information or any other information or opinions contained herein, for any purpose whatsoever. Except as required by applicable law, Galderma has no intention or obligation to update, keep updated or revise this announcement or any parts thereof. View source version on Contacts For further information: Christian Marcoux, Communications +41 76 315 26 50 Richard HarbinsonCorporate Communications +41 76 210 60 62 Emil IvanovHead of Strategy, Investor Relations, and +41 21 642 78 12 Jessica CohenInvestor Relations and Strategy +41 21 642 76 43
